Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fabio Angeli, Gianpaolo Reboldi, Giovanni Mazzotta, Cristina Poltronieri & Paolo Verdecchia. (2012) Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview. Expert Opinion on Drug Safety 11:4, pages 659-670.
Read now
Read now
Roberto Fogari & Annalisa Zoppi. (2010) New class of agents for treatment of hypertension: focus on direct renin inhibition. Vascular Health and Risk Management 6, pages 869-882.
Read now
Read now
Kunal Chaudhary, Ravi Nistala & Adam Whaley-Connell. (2010) Is there a future for direct renin inhibitors?. Expert Opinion on Investigational Drugs 19:5, pages 653-661.
Read now
Read now
Thomas W. Littlejohn$suffix/text()$suffix/text(), Peter Trenkwalder, Geert Hollanders, Yanxing Zhao & Weichi Liao. (2009) Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension. Current Medical Research and Opinion 25:4, pages 951-959.
Read now
Read now
Articles from other publishers (13)
Saeed Alshahrani. (2023) Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review. Frontiers in Pharmacology 14.
Crossref
Crossref
Yuta Tamemoto, Yukihiro Shibata, Natsumi Hashimoto, Hiromi Sato & Akihiro Hisaka. (2023) Involvement of multiple cytochrome P450 isoenzymes in drug interactions between ritonavir and direct oral anticoagulants. Drug Metabolism and Pharmacokinetics, pages 100498.
Crossref
Crossref
Erika D. Feller. 2017. Heart Failure. Heart Failure
85
96
.
Hisakazu Komori & Ikumi Tamai. (2014) Transporter-mediated drug interaction. Folia Pharmacologica Japonica 143:5, pages 243-248.
Crossref
Crossref
Jasper Dingemanse & Laurent Nicolas. (2013) Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects. Clinical Drug Investigation 33:3, pages 207-213.
Crossref
Crossref
Vicente Bertomeu Martínez, Mariano de la Figuera & Carlos Calvo. (2011) Inhibición directa de la renina y protección de órganos diana. Más allá del descenso de la presión. Revista Española de Cardiología Suplementos 11, pages 18-24.
Crossref
Crossref
Jamie J. Coleman, Anthony R. Cox & Nicholas J. Cowley. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
413
435
.
Zafar H Israili, Manuel Velasco & Valmore Bermúdez. (2010) Direct Renin Inhibitors as Antihypertensive Agents. American Journal of Therapeutics 17:3, pages 237-254.
Crossref
Crossref
Icilma V. Fergus. (2009) Antihypertensive Pharmacotherapy: Adverse Effects of Medications Promote Nonadherence. Journal of the CardioMetabolic Syndrome 4:1, pages E1-E3.
Crossref
Crossref
Hiddo J Lambers Heerspink, Vlado Perkovic & Dick de Zeeuw. (2009) Renal and cardio-protective effects of direct renin inhibition: a systematic literature review. Journal of Hypertension 27:12, pages 2321-2331.
Crossref
Crossref
C Venkata S Ram. (2009) Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease. Future Cardiology 5:5, pages 453-465.
Crossref
Crossref
Fedor Simko & Olga Pechanova. (2009) Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. Journal of Pineal Research 47:2, pages 127-133.
Crossref
Crossref
Raymond Vanholder, Angel Argilés, Joachim Beige, Philippe Brunet, Tilman B. Drüeke, Danilo Fliser, Stefan Herget-Rosenthal, Walter H. Hörl, Achim Jörres, Alessandra Perna, Mariano Rodriguez-Portillo, Goce Spasovski, Bernd Stegmayr, Peter Stenvinkel, Christoph Wanner, Andrzej Wiecek & Ziad A. Massy. (2009) Conservative Treatment of the Uremic Syndrome. Seminars in Dialysis 22:4, pages 449-453.
Crossref
Crossref